This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
How Plexus (PLXS) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Plexus (PLXS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Plexus (PLXS) Q4 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) fiscal fourth-quarter revenues are fueled by strong demand in Healthcare/Life Sciences and Industrial/Commercial sectors, and higher Europe, Middle East and Africa (EMEA) revenues.
Plexus (PLXS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 34.23% and 4.56%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: KNSL, PLXS, FMNB, DHI and LL
by Zacks Equity Research
Zacks.com featured highlights include: KNSL, PLXS, FMNB, DHI and LL
Buy These 5 Low Leverage Stocks Amid Market Turbulence
by Aparajita Dutta
Investors should choose stocks wisely amid these uncertain times as debt-ridden stocks bear high risk of solvency
How Plexus (PLXS) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Plexus (PLXS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Plexus (PLXS) Up 0.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Moving Average Crossover Alert: Plexus
by Zacks Equity Research
Plexus is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Plexus (PLXS) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) third-quarter results reflect robust performance in Healthcare/Life Sciences and Industrial/Commercial sectors, and higher Asia-Pacific (APAC) revenues.
Plexus (PLXS) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 60.00% and 6.92%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Plexus (PLXS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Plexus (PLXS) Up 7.2% Since Last Earnings Report?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Plexus' (PLXS) second-quarter results reflect weakness in Healthcare/Life Sciences and Communications sectors and lower revenues from Americas (AMER).
Plexus (PLXS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 12.96% and 3.87%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Tech Stocks Apr 22 Earnings Roster: APH, LRCX, NTGR & More
by Aniruddha Ganguly
Here we take a sneak peek at the earnings releases of tech stocks scheduled to report on Apr 22.
Should You Buy Plexus (PLXS) Ahead of Earnings?
by Zacks Equity Research
Plexus (PLXS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate Plexus (PLXS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Plexus (PLXS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Plexus' (PLXS) first-quarter results reflect robust revenues from Healthcare/Life Sciences, Industrial/Commercial and Aerospace/Defense sectors.
Plexus (PLXS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 7.53% and 6.36%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Fourth Quarter Earnings Reports in Week Ahead
by Zacks Equity Research
Fourth Quarter Earnings Reports in Week Ahead
On MLK Day, a Busy Week Expected
by Mark Vickery
Q4 earnings season, the World Economic Forum in Davos and President Trump's impeachment trial all get underway beginning tomorrow.
Plexus (PLXS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Tech Stocks Likely to Maintain Solid Momentum in 2020
by Shalu Saraf
Here we pick five technology stocks that are likely to maintain their solid momentum in 2020.